Hoyoung Huh - Director, 10%+ Owner at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
AKTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Hoyoung Huh since 4/23/2024

Holdings reported by Hoyoung Huh for Akari Therapeutics Plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares, par value $0.0001 per share 7.61B $9.13M $0.00 Nov 14, 2024 Direct
American Depositary Shares representing Ordinary Shares 4.7M $5.26M $1.12 Mar 20, 2025 Direct
Series A Warrants (Right to Buy) 893K $1M $1.12 Mar 6, 2025 Direct American Depositary Shares representing Ordinary Shares
Series B Warrants (Right to Buy) 893K $1M $1.12 Mar 6, 2025 Direct American Depositary Shares representing Ordinary Shares
Ordinary Shares, par value $0.0001 per share 219M $263K $0.00 Nov 14, 2024 By Hannol Ventures LLC
American Depositary Shares representing Ordinary Shares 109K $123K $1.12 Mar 20, 2025 Hannol Ventures LLC
Stock Option (Right to Buy) 225K Mar 20, 2025 Direct American Depositary Shares representing Ordinary Shares

Transactions reported by Hoyoung Huh for Akari Therapeutics Plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.